731 related articles for article (PubMed ID: 31881765)
21. The effects of cannabidiol on male reproductive system: A literature review.
Carvalho RK; Andersen ML; Mazaro-Costa R
J Appl Toxicol; 2020 Jan; 40(1):132-150. PubMed ID: 31313338
[TBL] [Abstract][Full Text] [Related]
22. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.
Luz-Veiga M; Azevedo-Silva J; Fernandes JC
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259306
[TBL] [Abstract][Full Text] [Related]
23. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
24. An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.
Morales P; Reggio PH; Jagerovic N
Front Pharmacol; 2017; 8():422. PubMed ID: 28701957
[TBL] [Abstract][Full Text] [Related]
25. Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol.
Ghovanloo MR; Dib-Hajj SD; Goodchild SJ; Ruben PC; Waxman SG
Front Physiol; 2022; 13():1066455. PubMed ID: 36439273
[TBL] [Abstract][Full Text] [Related]
26. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Eur J Neurosci; 2007 Apr; 25(7):2093-102. PubMed ID: 17419758
[TBL] [Abstract][Full Text] [Related]
27.
Watt G; Karl T
Front Pharmacol; 2017; 8():20. PubMed ID: 28217094
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases.
Naya NM; Kelly J; Hogwood A; Abbate A; Toldo S
Expert Opin Investig Drugs; 2024 May; ():. PubMed ID: 38703078
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of the antipsychotic properties of cannabidiol in humans.
Iseger TA; Bossong MG
Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
[TBL] [Abstract][Full Text] [Related]
30. Synthetic Strategies for (-)-Cannabidiol and Its Structural Analogs.
Jung B; Lee JK; Kim J; Kang EK; Han SY; Lee HY; Choi IS
Chem Asian J; 2019 Nov; 14(21):3749-3762. PubMed ID: 31529613
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
Juknat A; Kozela E; Kaushansky N; Mechoulam R; Vogel Z
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):289-96. PubMed ID: 26540221
[TBL] [Abstract][Full Text] [Related]
33. The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA
Bakas T; van Nieuwenhuijzen PS; Devenish SO; McGregor IS; Arnold JC; Chebib M
Pharmacol Res; 2017 May; 119():358-370. PubMed ID: 28249817
[TBL] [Abstract][Full Text] [Related]
34. Stable Isotope Ratio Analysis for Authentication of Natural Antioxidant Cannabidiol (CBD) from
Perini M; Gaggiotti A; Pianezze S; Ziller L; Larcher R
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507959
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
Straiker A; Dvorakova M; Zimmowitch A; Mackie K
Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
[TBL] [Abstract][Full Text] [Related]
36. Research progress in the management of vascular disease with cannabidiol: a review.
Guo Y; Wei R; Deng J; Guo W
J Cardiothorac Surg; 2024 Jan; 19(1):6. PubMed ID: 38172934
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
[TBL] [Abstract][Full Text] [Related]
38. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
40. New Methods for the Synthesis of Cannabidiol Derivatives.
Lago-Fernandez A; Redondo V; Hernandez-Folgado L; Figuerola-Asencio L; Jagerovic N
Methods Enzymol; 2017; 593():237-257. PubMed ID: 28750806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
